Early Detection of Cancer
"Early Detection of Cancer" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods to identify and characterize cancer in the early stages of disease and predict tumor behavior.
| Descriptor ID |
D055088
|
| MeSH Number(s) |
E01.390.500
|
| Concept/Terms |
Cancer Screening Tests- Cancer Screening Tests
- Cancer Screening Test
- Screening Test, Cancer
- Screening Tests, Cancer
- Test, Cancer Screening
- Tests, Cancer Screening
|
Below are MeSH descriptors whose meaning is more general than "Early Detection of Cancer".
Below are MeSH descriptors whose meaning is more specific than "Early Detection of Cancer".
This graph shows the total number of publications written about "Early Detection of Cancer" by people in this website by year, and whether "Early Detection of Cancer" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 3 | 4 |
| 2010 | 5 | 3 | 8 |
| 2011 | 3 | 10 | 13 |
| 2012 | 4 | 5 | 9 |
| 2013 | 8 | 6 | 14 |
| 2014 | 6 | 10 | 16 |
| 2015 | 13 | 14 | 27 |
| 2016 | 6 | 8 | 14 |
| 2017 | 10 | 14 | 24 |
| 2018 | 8 | 7 | 15 |
| 2019 | 10 | 11 | 21 |
| 2020 | 6 | 10 | 16 |
| 2021 | 6 | 14 | 20 |
| 2022 | 3 | 17 | 20 |
| 2023 | 0 | 18 | 18 |
| 2024 | 18 | 3 | 21 |
| 2025 | 27 | 5 | 32 |
| 2026 | 15 | 1 | 16 |
To return to the timeline,
click here.
Below are the most recent publications written about "Early Detection of Cancer" by people in Profiles.
-
Time to Cancer Screening Completion Following an SMS Reminder Intervention in a Large Federally Qualified Health Center Network: Secondary Data Analysis. JMIR Mhealth Uhealth. 2026 09 03; 14:e93912.
-
Heuriskance: a novel paradigm for systematic earlier detection of sporadic pancreatic cancer. J Natl Cancer Inst. 2026 Aug 01; 118(8):1353-1363.
-
Biomarker-Based Eligibility for Lung Cancer Screening: Validation of the Protein-Based INTEGRAL-Risk Model. JAMA. 2026 Jul 28; 336(4):323-333.
-
Cost-effectiveness of HES V2.0 and GALAD for hepatocellular carcinoma surveillance in patients with cirrhosis. Hepatol Commun. 2026 Aug 01; 10(8).
-
Barriers to cervical cancer screening and experiences using mailed at-home HPV self-collection kits among US and foreign-born Hispanic women in a safety net health system. Gynecol Oncol. 2026 Aug; 211:238-245.
-
Estimating stage-specific lung cancer costs for economic evaluation of LDCT screening in Ireland: a patient-level microsimulation. BMC Health Serv Res. 2026 Jul 11; 26(1).
-
Individual and Co-Occurring Social Needs, and Breast and Cervical Cancer Screening Among Patients in Texas Federally Qualified Health Centers. J Prim Care Community Health. 2026 Jan-Dec; 17:21501319261448952.
-
Towards early detection of pancreatic cancer: The current status of cohort studies by the Diabetes-Pancreatic Ductal AdenoCarcinoma Working Group. Pancreatology. 2026 Aug; 26(5):659-663.
-
Development of a multiplex assay for early detection of pancreatic cancer in high-risk groups. BMC Cancer. 2026 Apr 21; 26(1).
-
Development and validation of risk stratification models for hepatocellular cancer: A framework from the translational liver cancer consortium. Hepatology. 2026 Nov 01; 84(5):1587-1604.